Navigation Links
ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations
Date:7/31/2008

The American Society for Microbiology (ASM) and the Foundation for Innovative New Diagnostics (FIND) have signed a Memorandum of Understanding today confirming their agreement to work in partnership for projects aimed at strengthening infectious disease diagnosis and service integration in resource-poor and transitional countries.

"The collaboration between the ASM and FIND will focus on strengthening the foundation for infectious disease diagnosis in resource-poor nations, providing novel diagnostics and laboratory expertise for tuberculosis and other infectious diseases that are appropriate to the unique circumstances found in developing nations," says Steven Specter, Chair of the ASM's International Laboratory Capacity Building Committee.

The memorandum of understanding signed by the ASM and FIND arises from a pilot project that the two organizations have been conducting in Cote d'Ivoire since April 2008. In the pilot collaboration, FIND is developing and providing rapid, accurate and affordable tuberculosis diagnostic tests that can be effectively deployed in resource poor areas while the ASM is sending experts in clinical microbiology to provide training and technical assistance in the implementation of these new tests.

"We expect our partnership to reinforce the expansion and further development of quality-assured laboratory services as part of a larger framework of health system strengthening within resource-poor settings. Combating poverty-related infectious diseases with the development and rapid introduction of new diagnostic tests where they are most needed is why partnerships like the one between FIND and ASM are extremely important," says Giorgio Roscigno, CEO of FIND.

The WHO estimates that 2 billion people, or approximately one third of the world's population, are infected with the bacteria that cause tuberculosis. Africa represents 28% of all tuberculosis cases and has the highest infection rate per capita. Tuberculosis is a leading cause of death among people living with HIV/AIDS and most of the world's 200,000 HIV/TB deaths occur in Africa.

One of the primary challenges is that modern diagnostic tools for tuberculosis in industrialized countries are not suited to the infrastructure of resource poor nations where in some cases just getting reliable electricity is a problem. New, reliable diagnostics that can be effectively implemented in developing nations, as well as the expertise to use them, are urgently needed.

FIND is prioritizing tests that can be adopted at the lowest level of the health system, where a large number of patients first seek care. The technologies targeted for each level are intended to match the human resources available and the degree of complexity of the diagnostic question. Some of the diagnostic tools expected to be introduced into control programs will be incremental improvements on existing technologies while others will be radically new.

ASM, through its International Laboratory Capacity Building program, is ensuring the quality-assured implementation of new and existing diagnostic tools in resource-limited countries through onsite training and technical assistance. For this purpose, ASM is strengthening clinical microbiology laboratories by mobilizing its members to build human resource capacity for diagnosis of tuberculosis and other infectious diseases.

The memorandum of understanding is expected to serve as the beginning of a close collaboration between the ASM and FIND towards maximizing their complementary strengths and contributions to global health efforts.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. IBM and ETH Zurich form strategic partnership in nanoscience
2. Gladstone and Izumi Bio in partnership in regenerative medicine and cardiovascular disease
3. bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology
4. Entrust, Hewlett Packard Partner to Deploy Taiwanese ePassports, Authenticate Biometric Data
5. Smart greenhouse research partnership unveiled
6. National Lung Cancer Partnership and LUNGevity Foundation
7. National Lung Cancer Partnership announces winner of 2007 Career Development Award
8. Springer expands publishing partnership with the Biomedical Engineering Society
9. Plant Physiology and TAIR partnership will provide genetic information to public database
10. KAUST announces academic excellence alliance partnership with Imperial College London
11. Cell Press announces new partnership with the Biophysical Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... Calif. (PRWEB) , ... February 24, 2017 , ... Chef ... and wine scene. Making stops in several cities, she gained a number of ... adventure began in Stellenbosch, a town in South Africa’s Western Cape province. It ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
Breaking Biology Technology: